Skip to main content
Journal cover image

Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly.

Publication ,  Journal Article
Hannah, WB; Ryan, K; Pendyal, S; Burrow, TA; Harley, SE; Cordell, M; McCall, CM; Mavis, AM; Tan, QK-G; Kishnani, PS
Published in: Am J Med Genet A
November 2022

There is a broad differential diagnosis of infantile hepatosplenomegaly, with some etiologies being debilitating and treatable. A structured approach to history, examination, and laboratory and radiographic findings is important in diagnosis. Herein, we present a case of Wolman disease presenting as hepatosplenomegaly in an infant. This case details important learning points to help distinguish the diagnosis of Wolman disease from other conditions with overlapping clinical features, such as hemophagocytic lymphohistiocytosis (HLH). The advent of enzyme replacement therapy has dramatically changed the natural history of Wolman disease, and this child showed remarkable improvement with treatment. This child was later found to have extensive adenopathy with retroperitoneal lymph node biopsy demonstrating diffuse infiltration by lipid-laden macrophages, fatty deposits, cholesterol crystals, and calcifications. Similar to the collection of characteristic cells in other lysosomal storage disorders, we postulate that this is characteristic of underlying Wolman disease. We conclude with a summary of learning points from this presentation on infantile hepatosplenomegaly, pertinent to the geneticist, pediatrician, and pediatric subspecialists.

Duke Scholars

Published In

Am J Med Genet A

DOI

EISSN

1552-4833

Publication Date

November 2022

Volume

188

Issue

11

Start / End Page

3364 / 3368

Location

United States

Related Subject Headings

  • Wolman Disease
  • Splenomegaly
  • Lymphohistiocytosis, Hemophagocytic
  • Lipids
  • Infant
  • Humans
  • Hepatomegaly
  • Cholesterol
  • Child
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hannah, W. B., Ryan, K., Pendyal, S., Burrow, T. A., Harley, S. E., Cordell, M., … Kishnani, P. S. (2022). Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly. Am J Med Genet A, 188(11), 3364–3368. https://doi.org/10.1002/ajmg.a.62923
Hannah, William B., Katherine Ryan, Surekha Pendyal, T Andrew Burrow, Susan E. Harley, Miranda Cordell, Chad M. McCall, Alisha M. Mavis, Queenie K-G Tan, and Priya S. Kishnani. “Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly.Am J Med Genet A 188, no. 11 (November 2022): 3364–68. https://doi.org/10.1002/ajmg.a.62923.
Hannah WB, Ryan K, Pendyal S, Burrow TA, Harley SE, Cordell M, et al. Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly. Am J Med Genet A. 2022 Nov;188(11):3364–8.
Hannah, William B., et al. “Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly.Am J Med Genet A, vol. 188, no. 11, Nov. 2022, pp. 3364–68. Pubmed, doi:10.1002/ajmg.a.62923.
Hannah WB, Ryan K, Pendyal S, Burrow TA, Harley SE, Cordell M, McCall CM, Mavis AM, Tan QK-G, Kishnani PS. Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly. Am J Med Genet A. 2022 Nov;188(11):3364–3368.
Journal cover image

Published In

Am J Med Genet A

DOI

EISSN

1552-4833

Publication Date

November 2022

Volume

188

Issue

11

Start / End Page

3364 / 3368

Location

United States

Related Subject Headings

  • Wolman Disease
  • Splenomegaly
  • Lymphohistiocytosis, Hemophagocytic
  • Lipids
  • Infant
  • Humans
  • Hepatomegaly
  • Cholesterol
  • Child
  • 3202 Clinical sciences